Clostridial toxin derivatives and methods for treating pain

Details Clostridial toxin derivatives and methods for treating pain Clostridial toxin derivatives and methods for treating pain

2006-08-22

2008-08-19

Kam, Chih-Min (Department: 1656)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C424S236100, C424S009100, C514S002600, C514S012200, C530S350000, C435S252700

Reexamination Certificate

active

07413742

ABSTRACT:
Agents for treating pain, methods for producing the agents and methods for treating pain by administration to a patient of a therapeutically effective amount of the agent. The agent can include aclostridialneurotoxin, or a component or fragment or derivative thereof, attached to a targeting moiety, wherein the targeting moiety is selected from a group consisting of transmission compounds which can be released from neurons upon the transmission of pain signals by the neurons, and compounds substantially similar to the transmission compounds.

REFERENCES:
patent: 4189426 (1980-02-01), Li
patent: 4481139 (1984-11-01), Folkers et al.
patent: 4664911 (1987-05-01), Uhr et al.
patent: 4719231 (1988-01-01), Umezawa et al.
patent: 5410019 (1995-04-01), Coy et al.
patent: 5714468 (1998-02-01), Binder
patent: 5744131 (1998-04-01), Edwards et al.
patent: 5766605 (1998-06-01), Sanders et al.
patent: 5846216 (1998-12-01), Gonzales et al.
patent: 5861284 (1999-01-01), Nishimura et al.
patent: 5891842 (1999-04-01), Kream
patent: 5965406 (1999-10-01), Murphy
patent: 5989545 (1999-11-01), Foster et al.
patent: 6632440 (2003-10-01), Quinn et al.
patent: 7138127 (2006-11-01), Donovan
patent: 9532738 (1995-07-01), None
patent: 9633273 (1996-10-01), None
patent: 9801754 (1998-01-01), None
patent: 9807864 (1998-02-01), None
patent: 9917806 (1999-04-01), None
XP-00857076, Mosaic Structres of Neurotoxins Produced from Clostridium botulinum types C and D organisms, Morishi et al, Biochimca et Biophysica Acta, 1307 (1996) 123-126.
XP001011356, Berge, O-G et al, Selective Neurotoxic Lesions of Descending Serotonergic and Noadrenergic Pathways In the Rat, Journal of Neurochemistry; 44(4):1156-1161(1985).
XP001012206, Benollel, R et al, Actions of intrathecal diphtheria toxin-substance P fusion protein on models of persistent pain, Pain; 79(2-3):243-253(1999).
XP001011386, Garzon, J et al, Effect of intrathecal injection of pertusis toxin on substance P norepinephrine and serotonin contents in various neural structures of arthritic rats, Life Sciences; 47(21);1915-1924(1990).
Ueda, “In vivo Molecular Signal Transduction . . . ” Jpn J Pharmacol. vol. 79, 1999, pp. 263-268.
Nichols et al, “Transmission of Chronic Nociception . . . ” Science, vol. 286, Nov. 1999, pp. 1558-1561.
Lopes & Couture, “Localization of Bradykinin-Like . . . ” Neuroscience, vol. 78, 1997, pp. 481-497.
Vigna et al, “Characterization of Antibodies . . . ” J Nerosci, vol. 14, 1994, pp. 834-845.
Principles of Neural Science Third Edition, Edited by Kandel et al.
Babenko etal, “Experimental Human Muscle Pain . . . ” Pain, vol. 82, 1999, pp. 1-8.
Garrison & Rall, “Autacoids; Drug Therapy of Inflammation”.
Henry, “Substance P and Inflammatory . . . ” Disease Therapy, 1993.
Tsuda et al “In vivo Pathway . . . ” Br J Pharmacol, vol 127, 1999, pp. 449-456.
Welch et al, “Sensitivity of Embryonic Rat . . . ” Toxicon, vol. 38, 2000, pp. 245-258.
Mathias et al, “Topical Casaicin for Chronic Neck Pain..” Abstract, American Journal of Physical Medicine &Rehabilitation, vol. 74, 1995, pp. 39-44.
Furst, “Transmitters Involved in Antinociception in the Spinal Cord” Abstract, Brain Research Bulletin, vol. 48, 1999, pp. 129-141.
Poulain et al, Inhibition of Transmitter Release by Botulinum Neurotoxin A Eur.J.Biochem, vol. 185, 1989, pp. 197-203.
van Hagen et al, “Neuropeptides and Their Receptors” Ann Med, vol. 31 suppl2, pp. 15-22.
Principles of Neural Science Third Edition, Edited by Kandel et al, p. 395, 1992.
Garrison & Rall “Autacoids: Drug Therapy of Inflammation” in Goodman & Gilman's Pharmacological Basis of Therapeutics (Eighth Ed.) (Editors:Gilman, Rall, Nies & Taylor) p. 574-599 (1990).
Henry, “Substance P and Inflammatory . . . ” Disease Therapy, 1993, p. 75-87.
van Hagen et al, “Neuropeptides and Their Receptors” The Finish Medical Society Duodecim, Ann. Med., vol. 31 suppl2, pp. 15-22, 1992.

Affiliated with

Also associated with

Rating

Clostridial toxin derivatives and methods for treating pain does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Clostridial toxin derivatives and methods for treating pain, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clostridial toxin derivatives and methods for treating pain will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3994413